Fresenius Medical Care AG (FMS) Shares Outstanding (Weighted Average) (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $339.0 million in Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 8.11% year-over-year to $339.0 million; the TTM figure through Dec 2025 stood at $339.0 million (up 8.11% YoY), while the FY2025 annual figure was $339.0 million, up 8.11% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $339.0 million in Q4 2025, from $52.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $353.3 billion in Q1 2021 and bottomed at $947661.1 in Q2 2024.
• A 5-year average of $109.3 billion and a median of $314.6 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 16230117.21% — and 2024, when it slumped 100.0%.
• Year by year, Shares Outstanding (Weighted Average) stood at $335.1 million in 2021, then dropped by 10.72% to $299.2 million in 2022, then advanced by 5.52% to $315.7 million in 2023, then slipped by 0.68% to $313.5 million in 2024, then climbed by 8.11% to $339.0 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $339.0 million (Q4 2025), $52.4 million (Q2 2025), and $119.0 million (Q1 2025), per Business Quant data.

Peer Comparison